Health Care Innovation
Business & Economics
Improving the Incentive to Innovate
PRI Releases New Brief on the Benefits of Improving Incentives for Health Care Innovations San Francisco, June 22, 2015 – The Pacific Research Institute, a non-partisan, non-profit think tank based in San Francisco, today announced the release of a new brief: “Improving the Incentive to Innovate: An Important Benefit of ...
Commentary
Empowering Frivolous Healthcare Litigation Does Not Help Patients
Of all the problems troubling the U.S. healthcare system, too little litigation is not one of them. And yet, the “Creating and Restoring Equal Access to Equivalent Samples Act of 2016” (CREATES Act), which is currently being rushed through Congress, takes just such an approach. If implemented, the CREATES Act ...
Commentary
Medicare Drug Reimbursement Cuts Are Backdoor Rationing
Imagine being denied treatment for cancer because Washington bureaucrats decided that a cutting-edge new therapy that could cure you just wasn’t “cost effective.” That’s already happening in Britain under its government-run health care system, the National Health Service. And Medicare officials are poised to bring similar policies here. The NHS’s ...
Commentary
Putting Cost Ahead of Medical Outcomes
Unlike most markets, prices do not convey value in health care. In light of this problem, the Boston-based Institute for Clinical and Economic Review has been attempting to calculate the value of new medical technologies in order to assign a reasonable price to the latest innovations. The Blue Shield of ...
Commentary
Trump’s Healthcare Plan: Right Diagnosis, Wrong Prescription
Donald Trump recently released a healthcare reform plan. If only he had spent as much time crafting it as he does his hair. The GOP frontrunner is right that Obamacare has failed to fix what ails America’s healthcare system. As Trump put it, the Affordable Care Act has “tragically but ...
Commentary
Donald Trump’s Obamacare Alternative Isn’t Bad, But It Isn’t Great Either
“Repeal and replace with something terrific.” That was Donald Trump’s promise for how he’d deal with Obamacare shortly after he announced his candidacy in June. Trump has finally revealed just what he meant by “terrific.” Last week, he released a seven-point plan outlining his alternative to Obamacare. Trump calls it ...
Commentary
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary
The Health Care Sector Needs Innovation, Not Regulation
While problems with the U.S. health care system persist, the recent failures of the Affordable Care Act (ACA) illustrate that greater government regulation cannot cure what ails the U.S. health care industry. Deregulation that empowers private sector health care innovation can. In fact, private sector innovations, such as Dental Service ...
Commentary
The Senate should reject foreign drug importation
Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Commentary
Pharmaceutical Price Controls Risk Future Cures
Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
Improving the Incentive to Innovate
PRI Releases New Brief on the Benefits of Improving Incentives for Health Care Innovations San Francisco, June 22, 2015 – The Pacific Research Institute, a non-partisan, non-profit think tank based in San Francisco, today announced the release of a new brief: “Improving the Incentive to Innovate: An Important Benefit of ...
Empowering Frivolous Healthcare Litigation Does Not Help Patients
Of all the problems troubling the U.S. healthcare system, too little litigation is not one of them. And yet, the “Creating and Restoring Equal Access to Equivalent Samples Act of 2016” (CREATES Act), which is currently being rushed through Congress, takes just such an approach. If implemented, the CREATES Act ...
Medicare Drug Reimbursement Cuts Are Backdoor Rationing
Imagine being denied treatment for cancer because Washington bureaucrats decided that a cutting-edge new therapy that could cure you just wasn’t “cost effective.” That’s already happening in Britain under its government-run health care system, the National Health Service. And Medicare officials are poised to bring similar policies here. The NHS’s ...
Putting Cost Ahead of Medical Outcomes
Unlike most markets, prices do not convey value in health care. In light of this problem, the Boston-based Institute for Clinical and Economic Review has been attempting to calculate the value of new medical technologies in order to assign a reasonable price to the latest innovations. The Blue Shield of ...
Trump’s Healthcare Plan: Right Diagnosis, Wrong Prescription
Donald Trump recently released a healthcare reform plan. If only he had spent as much time crafting it as he does his hair. The GOP frontrunner is right that Obamacare has failed to fix what ails America’s healthcare system. As Trump put it, the Affordable Care Act has “tragically but ...
Donald Trump’s Obamacare Alternative Isn’t Bad, But It Isn’t Great Either
“Repeal and replace with something terrific.” That was Donald Trump’s promise for how he’d deal with Obamacare shortly after he announced his candidacy in June. Trump has finally revealed just what he meant by “terrific.” Last week, he released a seven-point plan outlining his alternative to Obamacare. Trump calls it ...
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
The Health Care Sector Needs Innovation, Not Regulation
While problems with the U.S. health care system persist, the recent failures of the Affordable Care Act (ACA) illustrate that greater government regulation cannot cure what ails the U.S. health care industry. Deregulation that empowers private sector health care innovation can. In fact, private sector innovations, such as Dental Service ...
The Senate should reject foreign drug importation
Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Pharmaceutical Price Controls Risk Future Cures
Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
